Peptide Protocol

App Store

Tell anesthesia about your GLP-1 before surgery

In 2023, the American Society of Anesthesiologists issued guidance recommending that patients on GLP-1 receptor agonists hold their dose before elective procedures. The reason: GLP-1s slow gastric emptying enough that a "fasted" patient can have substantial residual stomach contents — and inducing anesthesia in that state risks aspiration.

The aspiration risk

Anesthesia induction relaxes the upper esophageal sphincter and suppresses protective airway reflexes. If the stomach contains residual food or liquid, that content can move passively into the pharynx and be inhaled into the lungs. Aspiration is one of the most serious anesthesia complications — chemical pneumonitis, pneumonia, even death.

For decades, the standard preventive measure has been the "NPO after midnight" rule: no food for 8 hours, no clear liquids for 2 hours. The math assumes normal gastric emptying (1–2 hours for liquids, 4–6 for solids). On a GLP-1, gastric emptying can be 4–6× slower, and that math no longer works.

What the ASA guidance says

The 2023 American Society of Anesthesiologists consensus on GLP-1 receptor agonists and elective procedures:

1. Daily GLP-1 (liraglutide): hold the day-of-surgery dose.
2. Weekly GLP-1 (semaglutide, tirzepatide, dulaglutide): hold the dose for ≥1 week before the procedure.
3. Confirm prolonged fasting on the day: standard 8-hour fast may not be enough; some teams extend to 12+ hours.
4. Ultrasound gastric assessment if doubt remains. Bedside ultrasound can show whether the stomach is functionally empty.
5. Consider rapid-sequence induction (RSI) — a technique that minimizes aspiration risk — if there's any concern.

Disclosure protocol

Tell your anesthesiologist (and your surgeon, ideally beforehand) about:

• The exact drug (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, etc.).
• Your current dose.
• Your last injection date.
• How long you've been on the drug.
• Any recent dose change.
• Whether you've been told to hold or skip.

Don't assume the surgeon's office passed this along — repeat it to the anesthesia team on the day. They want to know.

Procedures where it matters

The risk applies to any procedure with significant sedation or general anesthesia:

• General anesthesia (any procedure). Highest concern. Hold per guidance.
• Deep sedation (colonoscopy, endoscopy). Disclose; the team may modify the protocol or assess gastric content.
• MAC (monitored anesthesia care, conscious sedation). Disclose; protective reflexes are partially intact but airway management can become urgent.
• Spinal/regional with light sedation. Disclose; usually OK with minimal modification.
• Local anesthesia only (dental, minor outpatient). Standard fasting rules apply; GLP-1 less concerning.

What "holding" actually means

For weekly GLP-1s, "hold 1 week" means skipping the dose scheduled for the surgery week, then resuming the regular schedule afterward. Plasma decays over several days but doesn't reach zero — even at one week, ~50% of plasma drug remains. The hold reduces stomach effects substantially but doesn't eliminate them.

For daily GLP-1s, "hold the day of" means skipping that morning's dose. Plasma drops to baseline within ~3 days; one missed dose is small.

What the actual data shows

Real-world studies have measured residual gastric content in fasted GLP-1 patients:

• ~50–70% of fasted GLP-1 patients have radiographic evidence of residual gastric content vs ~5–10% of non-GLP-1 controls.
• Aspiration events during anesthesia in GLP-1 patients: rare but documented; relative risk roughly 1.5–3× higher than non-GLP-1 controls.
• Most aspiration in GLP-1 patients occurs during induction; later phases of anesthesia have lower risk.

What if it's urgent and there's no time to hold?

Emergency surgery doesn't wait for GLP-1 plasma decay. The anesthesia team will use:

1. Pre-procedure metoclopramide (gastric motility stimulant).
2. Rapid-sequence induction with cricoid pressure.
3. Awake intubation in higher-risk cases.

These are reasonable mitigations. Disclose the GLP-1 even in urgent scenarios — the team can't apply them if they don't know.

After the procedure

Once the procedure is done and you're tolerating oral fluids, resume the GLP-1 on the original schedule for weekly drugs, or the next morning for daily drugs. Don't double-dose to catch up. See missed-dose rules.

FAQ

Related reading

Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.